The effect of Dipeptidyl peptidase 4 (DPP-4) inhibitors on hemoglobin level in diabetic kidney disease: A retrospective cohort study

Anemia typically develops early in the course of diabetic kidney disease (DKD). There are data to show that dipeptidyl-peptidase-4 (DPP-4) inhibitors affect hematopoietic growth factor activity and hemoglobin level. We retrospectively reviewed 443 DKD patients who were started on DDP-4 inhibitor the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Lingfeng, Chan, Gordon C.K., Ng, Jack K.C., Fung, Winston W.S., Chow, Kai-Ming, Szeto, Cheuk-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419505/
https://www.ncbi.nlm.nih.gov/pubmed/37565855
http://dx.doi.org/10.1097/MD.0000000000034538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419505/
https://www.ncbi.nlm.nih.gov/pubmed/37565855
http://dx.doi.org/10.1097/MD.0000000000034538

Ejemplares similares